Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Friday, April 19, 2024

Union Budget 2019 reaction from Mr.Satish Reddy, Chairman, Dr. Reddy’s Laboratories...

 New Delhi, July 06, 2019: "The expectations from the Union Budget 2019 were that of a bold reformist budget, however, it turned out to...

Skin care during the holiday season

Contributed by Dr. Sravya C Tipirneni, Consultant Dermatologist & Cosmetologist, Columbia Asia Hospital Whitefield New Delhi, January 10, 2020: With temperatures plummeting throughout most of the...

Biotechnology

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

Hearing Loss in the Digital Age: Understanding Noise-Induced Hearing Damage and Prevention

NEW DELHI, August 24, 2023:  Our lives are constantly evolving with a steady stream of information and entertainment flowing-in through technological advancements. With various...

IT & Software Support

Appointments

IML Names Sunder Rajan As Its Chief Executive Officer

Mumbai, July 01, 2019: Institute of Medicine and Law (IML - a business division of Corporate Law Academy Private Limited) has announced today that its...

Manipal Education & Medical Group (MEMG) Appoints Mr. Subrat Mohanty as Group President

New Delhi, June 08, 2019: Manipal Education & Medical Group (MEMG), a privately held conglomerate focused on education, healthcare and research, today announced the...

Awards

Financial Results

APL Apollo Quarterly Results.

APL Apollo Quarterly Results.

New Delhi, August 17, 2019: APL Apollo Tubes Limited (APL Apollo), India’s leading branded steel...

Approvals

Clinical Trails

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Asian eyelid Blepharoplasty: a trend among north eastern patients to create eyelid crease

By Dr. Parag Telang, Plastic & Reconstructive Surgeon and Director of Designer Bodyz Centre for advanced cosmetic surgery Among people who have an indistinct crease...

Over 12% surge in Corneal Donations post-pandemic at ICARE Eye Hospital Sector-26, Noida during...

Noida, September 07, 2023:  ICARE Eye Hospital in Sector-26 Noida reports a remarkable surge in corneal donations during the National Eye Donation Fortnight 2023,...

Product News

Festival aftermath for your skin and hair with The Tribe Concepts

New Delhi, November 12, 2021: Festivals leave the skin damaged with all the chemicals, pollution and dirt that sticks to the pores and penetrates...

Media Partners

Spotlight

Investments

Packaging

Latest News

4 essential supplements for a woman’s diet and how to incorporate them

New Delhi, March 04, 2022: Women’s bodies are naturally equipped to deal with the tremendous transformation that they go through. With pregnancy and periods...

104 Tiny Faces Light Up as Transworld Group Volunteers Create Art Experience for World...

New Delhi, February 29, 2024: Over 28 Transworld Group volunteers joined hands with St. Jude Childcare Centres – an  NGO, to spend time with...

Home Isolation Programme – A Boon for Covid-19 Patients with Mild Symptoms

80% of COVID-19 patients are asymptomatic or showing mild symptoms: Says Union Ministry of Health & Family Welfare's Report New Delhi, July 29, 2020: The...

NABH Certification for KIMS Emergency Department First in Telangana

Hyderabad, September 24, 2020: National Accreditation Board for Hospitals and Healthcare Providers (NABH), the constituent board of quality council of India, has certified the...

Dental Care

Tips to maintain oral health!

By Dr.MS Prasad, Dental Surgeon, Columbia Asia Referral Hospital Yeshwanthpur It has been said that a person’s real happiness begins from the plate and is...

Hospital Management

HCG Cancer Hospital completes Comprehensive Genomic Profi­ling (CGP) of 1000+ Cancer Patients

Bengaluru , August 22, 2023: Envisioned to drive a new standard of cancer care, Triesta Sciences, a Unit of HealthCare Global Enterprises Limited (HCG Cancer...

Drug Discovery & Development

Suppliers

Technology

Companies

Huge opportunities for AI in healthcare, manufacturing excerpts at FICCI...

Sanjeev Malhotra of NASSCOM says technology can make maximum difference in these two areas Ahmedabad, September 18, 2019: Adoption of Artificial Intelligence (AI) and Internet...

Marketing

Our Partners

Machinery & Equipments